Cargando…

Efficacy of combination therapy with gabapentin and guanfacine for paroxysmal sympathetic hyperactivity following hypoxic encephalopathy: a case report

Paroxysmal sympathetic hyperactivity (PSH) is a clinical syndrome of episodic sympathetic hyperactivities following severe acquired brain injury. It is characterized by paroxysmal hyperthermia, tachycardia, hypertension, tachypnea, excessive diaphoresis, and specific posturing. Although the persiste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyoshi, Takafumi, Mizushima, Chikaru, Noborio, Yayoi, Kimoto, Yasunori, Nakaharu, Yasue, Shimamoto, Shinsaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829780/ https://www.ncbi.nlm.nih.gov/pubmed/33900871 http://dx.doi.org/10.1177/03000605211009721

Ejemplares similares

Paroxysmal sympathetic hyperactivity in hemispheric intraparenchymal hemorrhage
por: Gao, Billy, et al.
Publicado: (2014)

Paroxysmal sympathetic hyperactivity in neurological critical care
por: Verma, Rajesh, et al.
Publicado: (2015)

Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity
por: Peng, Yuan, et al.
Publicado: (2017)

Paroxysmal Sympathetic Hyperactivity: An Old but Unrecognized Condition
por: Monteiro, Filipa Brás, et al.
Publicado: (2017)

Propranolol for Paroxysmal Sympathetic Hyperactivity with Lateralizing Hyperhidrosis after Stroke
por: Siefferman, Jason W., et al.
Publicado: (2015)

Understanding paroxysmal sympathetic hyperactivity after traumatic brain injury
por: Meyer, Kimberly S.
Publicado: (2014)

Paroxysmal sympathetic hyperactivity syndrome caused by fat embolism syndrome
por: Godoy, Daniel Agustin, et al.
Publicado: (2018)

Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
por: Pucks‐Faes, Elke, et al.
Publicado: (2018)

Thrombosis of the Vein of Galen: Pitfalls, Metamorphosis, and Paroxysmal Sympathetic Hyperactivity
por: Santos-Soares, Paulo César, et al.
Publicado: (2017)

Paroxysmal Sympathetic Hyperactivity in a Young Male with Glioblastoma Multiforme
por: Suliman, Mohamed S, et al.
Publicado: (2020)

Refractory Paroxysmal Sympathetic Hyperactivity Following Traumatic Intracerebral Hemorrhage
por: Malinovic, Matea, et al.
Publicado: (2021)

Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis
por: Chen, Zhongyun, et al.
Publicado: (2022)

Paroxysmal sympathetic hyperactivity syndrome in tuberculous meningitis with paradoxical reaction
por: Siahaan, Andre Marolop Pangihutan, et al.
Publicado: (2022)

Paroxysmal Sympathetic Hyperactivity: It is Time to Use the New Diagnostic Criteria
por: Krupanandan, Ravikumar
Publicado: (2022)

Paroxysmal Sympathetic Hyperactivity in Neurocritical Children: A Pilot Study
por: Agrwal, Shipra, et al.
Publicado: (2022)

Paroxysmal Sympathetic Hyperactivity after Cardiac Arrest in a Young Male
por: Singh, Tanveer, et al.
Publicado: (2018)

Identification and Management of Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury
por: Zheng, Rui-Zhe, et al.
Publicado: (2020)

Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: What Is Important to Know?
por: Louraoui, Sidi Mamoun, et al.
Publicado: (2022)

Non-infectious fever in cerebral arteriovenous malformation: Central fever or paroxysmal sympathetic hyperactivity
por: Mishra, Rajeeb K., et al.
Publicado: (2021)

Utility of Serum Procalcitonin in Diagnosing Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury
por: Bindra, Ashish, et al.
Publicado: (2021)

Paroxysmal Sympathetic Hyperactivity in a 73-Year-Old Female With Acute Myeloid Leukemia
por: Lokineni, Sravani, et al.
Publicado: (2021)

Effectiveness of Pharmacological Agents and Validation of Diagnostic Scales for the Management of Paroxysmal Sympathetic Hyperactivity in Hispanics
por: Abdelhakiem, Alaa K., et al.
Publicado: (2020)

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
por: Martinez-Raga, Jose, et al.
Publicado: (2015)

Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review
por: Lee, Seungjoo, et al.
Publicado: (2016)

Storms and silence: a case report of catatonia and paroxysmal sympathetic hyperactivity following cerebral hypoxia
por: Hamlin, Dallas Wolfgang, et al.
Publicado: (2020)

Diagnostic challenge of paroxysmal sympathetic hyperactivity (PSH) associated with diffuse axonal injury (DAI) in head trauma
por: Bueno González, AM, et al.
Publicado: (2014)

Paroxysmal sympathetic hyperactivity concurrent with hypothalamic injury in a patient with intracerebral hemorrhage: A case report
por: Jang, Sung Ho, et al.
Publicado: (2022)

Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model
por: Lukkes, J. L., et al.
Publicado: (2020)

Paroxysmal Sympathetic Hyperactivity in Moderate-to-Severe Traumatic Brain Injury and the Role of Beta-Blockers: A Scoping Review
por: Nguembu, Stéphane, et al.
Publicado: (2021)

Case Report: Dexmedetomidine for Intractable Clusters of Myoclonic Jerks and Paroxysmal Sympathetic Hyperactivity in Progressive Encephalomyelitis With Rigidity and Myoclonus
por: Fujino, Yuzo, et al.
Publicado: (2021)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Influence of paroxysmal sympathetic hyperactivity (PSH) on the functional outcome of neurological early rehabilitation patients: a case control study
por: Totikov, Alan, et al.
Publicado: (2019)

Diagnosis and Treatment of Paroxysmal Sympathetic Hyperactivity in Medical ICU, University of Gondar Hospital, Northwest Ethiopia: A Case Report
por: Bekele, Nebiyu, et al.
Publicado: (2020)

Case Report: Stroke Chameleon: Acute Large Vessel Occlusion in the Posterior Circulation With Paroxysmal Sympathetic Hyperactivity as the First Manifestation
por: Yin, Juntao, et al.
Publicado: (2022)

Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy
por: Ota, Toyosaku, et al.
Publicado: (2021)

Metabolite profiling of guanfacine in plasma and urine of healthy Japanese subjects after oral administration of guanfacine extended‐release tablets
por: Inoue, Yuji, et al.
Publicado: (2019)

Cerebral fat embolization with paroxysmal sympathetic hyperactivity syndrome and septic shock at high altitude: a case report and literature review
por: Li, Min, et al.
Publicado: (2021)

Clonidine safety and effectiveness in the management of suspected paroxysmal sympathetic hyperactivity post-traumatic brain injury: A retrospective cohort study
por: Alshaya, Abdulrahman I, et al.
Publicado: (2023)

Attention deficits following ADEM ameliorated by guanfacine
por: Singh-Curry, Victoria, et al.
Publicado: (2010)

Effect of Enteral Guanfacine on Dexmedetomidine Use in the ICU
por: Fetters, Megan B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vjrgdjuv469ji215rg8sgt8bt